Global Over the Counter Drugs Market Report and Forecast 2023-2031

Global Over the Counter Drugs Market Report and Forecast 2023-2031

Global Over the Counter Drugs Market Outlook

The global over-the-counter drugs (OTC) market is expected to grow at a significant rate due to the increasing prevalence of common ailments, rising healthcare expenditure, and growing awareness about self-medication are the key drivers of the market. The global over the counter drugs market size reached a value of USD 167.5 billion in 2022. The market is likely to grow at a CAGR of 6.9% in the forecast period of 2023-2031 to reach a market value of USD 304.4 billion by 2031.

Over the Counter Drugs Market: Introduction

The global over-the-counter drugs market report by Expert Market Research provides an in-depth analysis of the market and its segments. OTC drugs are those medications that can be purchased without a prescription from healthcare professionals. They are typically used for the treatment of common ailments such as cold, cough, pain, fever, allergies, and digestive problems. The report covers the market for OTC drugs, including various drug types, and provides a detailed analysis of the market size, growth, and trends.

OVER THE COUNTER DRUGS Market Segmentations

The market can be categorised into product type, formulation type, and Distribution channel.

Market Breakup by Product Type

  • Cough, Cold, and Flu Products
  • Analgesics
  • Dermatology Products
  • Vitamins, Minerals, and Supplements (VMS)
  • Weight Loss/Dietary Products
  • Ophthalmic Products
  • Sleeping Aids
  • Other Product Types
Market Breakup by Formulation Type
  • Tablets
  • Liquids
  • Ointments
  • Sprays
Market Breakup by Distribution Channel
  • Hospital Based Pharmacies
  • Online Pharmacies
  • Retail Pharmacies
Market Breakup by Region
  • North America
  • United States of America
  • Canada
  • Europe
  • United Kingdom
  • Germany
  • France
  • Italy
  • Others
  • Asia Pacific
  • China
  • Japan
  • India
  • ASEAN
  • Australia
  • Others
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Nigeria
  • South Africa
  • Others
Over the Counter Drugs Market Scenario

The global over-the-counter drugs market is experiencing significant growth due to several factors. One of the primary drivers is the increasing prevalence of common ailments such as cold, cough, pain, fever, allergies, and digestive problems. These health issues affect a large percentage of the population, leading to a high demand for OTC drugs.

Another driver of the market is the rising healthcare expenditure across the world. As healthcare costs continue to rise, people are increasingly turning to self-medication to manage their health conditions. This has led to an increase in the demand for OTC drugs, which are typically cheaper than prescription drugs.

The growing awareness about self-medication is also contributing to the growth of the market. Consumers are becoming more aware of the benefits of OTC drugs, such as convenience, accessibility, and cost-effectiveness. This has led to an increase in the adoption of self-medication, which is driving the demand for OTC drugs.

Moreover, the COVID-19 pandemic has also had a significant impact on the OTC drugs market. The pandemic has led to a surge in demand for OTC drugs such as cold and flu products, pain relievers, and vitamins and supplements. Consumers are increasingly turning to OTC drugs to manage their symptoms and boost their immunity.

North America dominates the OTC drugs market, followed by Europe and Asia Pacific. The high prevalence of common ailments, rising healthcare expenditure, and growing awareness about self-medication are driving the growth of the market in these regions. The Asia Pacific region is expected to grow at the highest CAGR during the forecast period, owing to the increasing adoption of self-medication, rising healthcare expenditure, and growing awareness about OTC drugs.

Key Players in the Global Over the Counter Drugs Market

The report gives an in-depth analysis of the key players involved in the Over-the-Counter Drugs market, sponsors manufacturing the drugs, and putting them through trials to get FDA approvals. The companies included in the market are as follows:
  • Johnson & Johnson Private Limited
  • Bayer AG
  • Novartis AG
  • Sanofi
  • Takeda Pharmaceutical Company Limited
  • Pfizer Inc.
  • GSK plc
  • Boehringer Ingelheim International GmbH
  • Reckitt Benckiser Group PLC
  • Procter & Gamble
  • Abbott
  • Perrigo Company plc.


1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation
2 Research Methodology
3 Executive Summary
4 Global Over the Counter Drugs Overview
4.1 Drug Overview
4.1.1 Pharmacodynamics
4.1.2 Pharmacokinetics
4.1.3 Adverse Events
5 Patient Profile
5.1 Patient Profile Overview
5.2 Patient Psychology and Emotional Impact Factors
5.3 Risk Assessment and Treatment Success Rate
5.4 Current Scenario Evaluation and Regulatory Framework
5.5 Emerging Therapies and Clinical Trials Synopsis
5.6 Patent Landscape
5.6.1 Patent Overview
5.6.1.1 Patent Status and Expiry
5.6.1.2 Timelines from Drug Development to Commercial Launch
5.6.1.3 New Drug Application
5.6.1.3.1 Documentation and Approval Process
5.7 Cost of Treatment
5.8 Investment Scenarios
5.9 Regulatory Framework
5.9.1 Regulatory Overview
5.9.1.1 US FDA
5.9.1.2 EU EMA
5.9.1.3 INDIA CDSCO
5.9.1.4 JAPAN PMDA
5.9.1.5 Others
6 Challenges and Unmet Needs
6.1 Treatment Pathway Challenges
6.2 Compliance and Drop-Out Analysis
6.3 Awareness and Prevention Gaps
7 Global Over the Counter Drugs Market
7.1 Global Over the Counter Drugs Market Overview
7.2 Global Over the Counter Drugs Market Analysis
7.2.1 Market Overview
7.2.1.1 Global Over the Counter Drugs Market Historical Value (2016-2022)
7.2.1.2 Global Over the Counter Drugs Market Forecast Value (2023-2031)
7.3 Global Over the Counter Drugs Market by Product Type
7.3.1 Market Overview
7.3.1.1 Cough, Cold, and Flu Products
7.3.1.2 Analgesics
7.3.1.3 Dermatology Products
7.3.1.4 Gastrointestinal Products
7.3.1.5 Vitamins, Minerals, and Supplements (VMS)
7.3.1.6 Weight Loss/Dietary Products
7.3.1.7 Ophthalmic Products
7.3.1.8 Sleeping Aids
7.3.1.9 Other Product Types
7.4 Global Over the Counter Drugs Market by Formulation Type
7.4.1 Market Overview
7.4.1.1 Tablets
7.4.1.2 Liquids
7.4.1.3 Ointments
7.4.1.4 Sprays
7.5 Global Over the Counter Drugs Market by Distribution Channel
7.5.1 Market Overview
7.5.1.1 Hospital Based Pharmacies
7.5.1.2 Online Pharmacies
7.5.1.3 Retail Pharmacies
7.6 Global Over the Counter Drugs Market by Region
7.6.1 Market Overview
7.6.1.1 North America
7.6.1.2 Europe
7.6.1.3 Asia Pacific
7.6.1.4 Latin America
7.6.1.5 Middle East and Africa
8 North America Over the Counter Drugs Market
8.1 Market Share by Country
8.2 United States of America
8.2.1 Historical Trend (2016-2022)
8.2.2 Forecast Trend (2023-2031)
8.3 Canada
8.3.1 Historical Trend (2016-2022)
8.3.2 Forecast Trend (2023-2031)
9 Europe Over the Counter Drugs Market
9.1 Market Share by Country
9.2 United Kingdom
9.2.1 Historical Trend (2016-2022)
9.2.2 Forecast Trend (2023-2031)
9.3 Germany
9.3.1 Historical Trend (2016-2022)
9.3.2 Forecast Trend (2023-2031)
9.4 France
9.4.1 Historical Trend (2016-2022)
9.4.2 Forecast Trend (2023-2031)
9.5 Italy
9.5.1 Historical Trend (2016-2022)
9.5.2 Forecast Trend (2023-2031)
9.6 Others
10 Asia Pacific Over the Counter Drugs Market
10.1 Market Share by Country
10.2 China
10.2.1 Historical Trend (2016-2022)
10.2.2 Forecast Trend (2023-2031)
10.3 Japan
10.3.1 Historical Trend (2016-2022)
10.3.2 Forecast Trend (2023-2031)
10.4 India
10.4.1 Historical Trend (2016-2022)
10.4.2 Forecast Trend (2023-2031)
10.5 ASEAN
10.5.1 Historical Trend (2016-2022)
10.5.2 Forecast Trend (2023-2031)
10.6 Australia
10.6.1 Historical Trend (2016-2022)
10.6.2 Forecast Trend (2023-2031)
10.7 Others
11 Latin America Over the Counter Drugs Market
11.1 Market Share by Country
11.2 Brazil
11.2.1 Historical Trend (2016-2022)
11.2.2 Forecast Trend (2023-2031)
11.3 Argentina
11.3.1 Historical Trend (2016-2022)
11.3.2 Forecast Trend (2023-2031)
11.4 Mexico
11.4.1 Historical Trend (2016-2022)
11.4.2 Forecast Trend (2023-2031)
11.5 Others
12 Middle East and Africa Over the Counter Drugs Market
12.1 Market Share by Country
12.2 Saudi Arabia
12.2.1 Historical Trend (2016-2022)
12.2.2 Forecast Trend (2023-2031)
12.3 United Arab Emirates
12.3.1 Historical Trend (2016-2022)
12.3.2 Forecast Trend (2023-2031)
12.4 Nigeria
12.4.1 Historical Trend (2016-2022)
12.4.2 Forecast Trend (2023-2031)
12.5 South Africa
12.5.1 Historical Trend (2016-2022)
12.5.2 Forecast Trend (2023-2031)
12.6 Others
13 Global Over the Counter Drugs Market Dynamics
13.1 Market Drivers and Constraints
13.2 Drug Adoption Parameters
13.3 SWOT Analysis
13.4 Porter Five Forces Model
13.5 Key Demand Indicators
13.6 Key Price Indicators
13.7 Industry Events, Initiatives, and Trends
13.8 Value Chain Analysis
14 Supplier Landscape
14.1 Johnson & Johnson Private Limited
14.1.1 Company Overview
14.1.2 Product Portfolio
14.1.3 Demographic Reach and Achievements
14.1.4 Mergers and Acquisitions
14.1.5 Certifications
14.2 Bayer AG
14.2.1 Company Overview
14.2.2 Product Portfolio
14.2.3 Demographic Reach and Achievements
14.2.4 Mergers and Acquisitions
14.2.5 Certifications
14.3 Novartis AG
14.3.1 Company Overview
14.3.2 Product Portfolio
14.3.3 Demographic Reach and Achievements
14.3.4 Mergers and Acquisitions
14.3.5 Certifications
14.4 Sanofi
14.4.1 Company Overview
14.4.2 Product Portfolio
14.4.3 Demographic Reach and Achievements
14.4.4 Mergers and Acquisitions
14.4.5 Certifications
14.5 Takeda Pharmaceutical Company Limited
14.5.1 Company Overview
14.5.2 Product Portfolio
14.5.3 Demographic Reach and Achievements
14.5.4 Mergers and Acquisitions
14.5.5 Certifications
14.6 Pfizer Inc.
14.6.1 Company Overview
14.6.2 Product Portfolio
14.6.3 Demographic Reach and Achievements
14.6.4 Mergers and Acquisitions
14.6.5 Certifications
14.7 GSK plc
14.7.1 Company Overview
14.7.2 Product Portfolio
14.7.3 Demographic Reach and Achievements
14.7.4 Mergers and Acquisitions
14.7.5 Certifications
14.8 Boehringer Ingelheim International GmbH
14.8.1 Company Overview
14.8.2 Product Portfolio
14.8.3 Demographic Reach and Achievements
14.8.4 Mergers and Acquisitions
14.8.5 Certifications
14.9 Reckitt Benckiser Group PLC
14.9.1 Company Overview
14.9.2 Product Portfolio
14.9.3 Demographic Reach and Achievements
14.9.4 Mergers and Acquisitions
14.9.5 Certifications
14.10 Procter & Gamble
14.10.1 Company Overview
14.10.2 Product Portfolio
14.10.3 Demographic Reach and Achievements
14.10.4 Mergers and Acquisitions
14.10.5 Certifications
14.11 Abbott
14.11.1 Company Overview
14.11.2 Product Portfolio
14.11.3 Demographic Reach and Achievements
14.11.4 Mergers and Acquisitions
14.11.5 Certifications
14.12 Perrigo Company plc.
14.12.1 Company Overview
14.12.2 Product Portfolio
14.12.3 Demographic Reach and Achievements
14.12.4 Mergers and Acquisitions
14.12.5 Certifications
15 Pricing Models and Strategies (Additional Insight)
15.1 Cost Model
15.1.1 Manufacturing Cost Analysis
15.1.2 Procurement Cost Analysis
15.2 Pricing Strategies
15.2.1 Competitor Pricing Analysis
15.2.2 Key Assessment of Product Attributes
15.2.3 Pricing Benchmark
16 Global Over the Counter Drugs Market- Distribution Model (Additional Insight)
16.1 Overview
16.2 Potential Distributors
16.3 Key Parameters for Distribution Partner Assessment

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings